Quick Answer
Corbus Pharmaceuticals Holdings, Inc. reported Common Stock Shares Outstanding of 17.61 million shares for the year ending 2025.
- Corbus Pharmaceuticals Holdings, Inc. showed an increase of +44.6% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Corbus Pharmaceuticals Holdings, Inc.'s annual report (Form 10-K), filed with the SEC on March 9, 2026.
- XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 13 years of available data (2013 to 2025), Corbus Pharmaceuticals Holdings, Inc.'s Common Stock Shares Outstanding has grown by 152.9%.
- Historical annual values: Fiscal year 2025: 17.61 million shares | Fiscal year 2024: 12.18 million shares | Fiscal year 2023: 4.42 million shares | Fiscal year 2022: 4.17 million shares | Fiscal year 2021: 4.17 million shares | Fiscal year 2020: 98.85 million shares | Fiscal year 2019: 64.67 million shares | Fiscal year 2018: 57.25 million shares | Fiscal year 2017: 55.60 million shares | Fiscal year 2016: 44.68 million shares | Fiscal year 2015: 37.61 million shares | Fiscal year 2014: 25.94 million shares | Fiscal year 2013: 6.96 million shares.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: